Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis
Chiara Saponaro, Melania Gaggini, Fabrizia Carli, et al.
Nutrients (2015) Vol. 7, Iss. 11, pp. 9453-9474
Open Access | Times Cited: 452

Showing 1-25 of 452 citing articles:

Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Mengwei Li, Xiaowei Chi, Ying Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 405
From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
Amalia Gastaldelli, Kenneth Cusi
JHEP Reports (2019) Vol. 1, Iss. 4, pp. 312-328
Open Access | Times Cited: 351
Regulation and Metabolic Significance of De Novo Lipogenesis in Adipose Tissues
Ziyi Song, Alus M. Xiaoli, Fajun Yang
Nutrients (2018) Vol. 10, Iss. 10, pp. 1383-1383
Open Access | Times Cited: 341
Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabolism Study
Amalia Gastaldelli, Melania Gaggini, Ralph A. DeFronzo
Diabetes (2017) Vol. 66, Iss. 4, pp. 815-822
Closed Access | Times Cited: 298
Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Vignan Manne, Priya Handa, Kris V. Kowdley
Clinics in Liver Disease (2017) Vol. 22, Iss. 1, pp. 23-37
Closed Access | Times Cited: 297
A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease
Zhonge Chen, Rong Yu, Ying Xiong, et al.
Lipids in Health and Disease (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 263
Changes in Plasma Free Fatty Acids Associated with Type-2 Diabetes
Amélie I. S. Sobczak, Claudia A. Blindauer, Alan J. Stewart
Nutrients (2019) Vol. 11, Iss. 9, pp. 2022-2022
Open Access | Times Cited: 251
Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review
Anna Pia Delli Bovi, F. Marcianò, Claudia Mandato, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 209
Determinants of body fat distribution in humans may provide insight about obesity-related health risks
Aaron P. Frank, Roberta de Souza Santos, Biff F. Palmer, et al.
Journal of Lipid Research (2018) Vol. 60, Iss. 10, pp. 1710-1719
Open Access | Times Cited: 205
Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease
Gianluca Svegliati‐Baroni, I. Pierantonelli, Pierangelo Torquato, et al.
Free Radical Biology and Medicine (2019) Vol. 144, pp. 293-309
Closed Access | Times Cited: 196
ANGPTL4 in Metabolic and Cardiovascular Disease
Binod Aryal, Nathan L. Price, Yajaira Suárez, et al.
Trends in Molecular Medicine (2019) Vol. 25, Iss. 8, pp. 723-734
Open Access | Times Cited: 169
Mechanisms of muscle insulin resistance and the cross‐talk with liver and adipose tissue
Simone C. da Silva Rosa, Nichole Nayak, Andrei Miguel Caymo, et al.
Physiological Reports (2020) Vol. 8, Iss. 19
Open Access | Times Cited: 154
Exercise Alleviates Obesity-Induced Metabolic Dysfunction via Enhancing FGF21 Sensitivity in Adipose Tissues
Leiluo Geng, Boya Liao, Leigang Jin, et al.
Cell Reports (2019) Vol. 26, Iss. 10, pp. 2738-2752.e4
Open Access | Times Cited: 152
Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator‐activated receptor α modulator (SPPARMα), versus placebo in patients with non‐alcoholic fatty liver disease
Atsushi Nakajima, Yuichiro Eguchi, Masato Yoneda, et al.
Alimentary Pharmacology & Therapeutics (2021) Vol. 54, Iss. 10, pp. 1263-1277
Open Access | Times Cited: 146
Measuring and estimating insulin resistance in clinical and research settings
Amalia Gastaldelli
Obesity (2022) Vol. 30, Iss. 8, pp. 1549-1563
Open Access | Times Cited: 103
FGF1 and insulin control lipolysis by convergent pathways
Gencer Sancar, Sihao Liu, Emanuel Gasser, et al.
Cell Metabolism (2022) Vol. 34, Iss. 1, pp. 171-183.e6
Open Access | Times Cited: 74
Obesity and diabetes
Chrysoula Boutari, Antea DeMarsilis, Christos S. Mantzoros
Diabetes Research and Clinical Practice (2023) Vol. 202, pp. 110773-110773
Closed Access | Times Cited: 57
Estrogens in Adipose Tissue Physiology and Obesity-Related Dysfunction
Alina Kuryłowicz
Biomedicines (2023) Vol. 11, Iss. 3, pp. 690-690
Open Access | Times Cited: 47
An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease
Le Zhang, Mortada El‐Shabrawi, Louise A. Baur, et al.
Med (2024) Vol. 5, Iss. 7, pp. 797-815.e2
Closed Access | Times Cited: 18
Pathophysiology of Non Alcoholic Fatty Liver Disease
Salvatore Petta, Amalia Gastaldelli, Eleni Rebelos, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 12, pp. 2082-2082
Open Access | Times Cited: 154
Prevalence of Pre-Diabetes across Ethnicities: A Review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for Classification of Dysglycaemia
Wilson Yip, Ivana R. Sequeira, Lindsay D. Plank, et al.
Nutrients (2017) Vol. 9, Iss. 11, pp. 1273-1273
Open Access | Times Cited: 140
New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
Nahúm Méndez‐Sánchez, Vania Cruz-Ramón, Oscar Ramírez-Pérez, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 7, pp. 2034-2034
Open Access | Times Cited: 140
Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver
Tomáš Jeleník, Kirti Kaul, Gilles Séquaris, et al.
Diabetes (2017) Vol. 66, Iss. 8, pp. 2241-2253
Open Access | Times Cited: 139
Obesity and Breast Cancer: Current Insights on the Role of Fatty Acids and Lipid Metabolism in Promoting Breast Cancer Growth and Progression
Christina Blücher, Sonja C. Stadler
Frontiers in Endocrinology (2017) Vol. 8
Open Access | Times Cited: 127
Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy
Rebecca J. Brown, Elif A Oral, Elaine Cochran, et al.
Endocrine (2018) Vol. 60, Iss. 3, pp. 479-489
Open Access | Times Cited: 110
Page 1 - Next Page

Scroll to top